BioNote Inc
KRX:377740
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 985
6 080
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cash Flow Statement
Cash Flow Statement
BioNote Inc
Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||
Net Income |
464 663
|
307 798
|
285 041
|
(68 973)
|
(155 974)
|
(20 497)
|
19 173
|
81 651
|
|
Depreciation & Amortization |
5 897
|
6 451
|
8 394
|
7 695
|
7 940
|
8 206
|
8 292
|
8 104
|
|
Other Non-Cash Items |
(74 951)
|
8 799
|
31 744
|
96 998
|
156 844
|
25 284
|
(12 320)
|
(72 211)
|
|
Cash Taxes Paid |
158 684
|
157 006
|
171 106
|
95 845
|
69 140
|
40 454
|
27 941
|
6 818
|
|
Cash Interest Paid |
82
|
84
|
84
|
86
|
544
|
603
|
664
|
676
|
|
Change in Working Capital |
(139 184)
|
(73 948)
|
(90 525)
|
9 755
|
8 280
|
(17 187)
|
6 483
|
33 006
|
|
Cash from Operating Activities |
256 425
N/A
|
249 100
-3%
|
234 653
-6%
|
45 475
-81%
|
17 090
-62%
|
(4 194)
N/A
|
21 628
N/A
|
50 550
+134%
|
|
Investing Cash Flow | |||||||||
Capital Expenditures |
(16 702)
|
(42 484)
|
(44 165)
|
(33 860)
|
(30 753)
|
(4 542)
|
(3 523)
|
(7 686)
|
|
Other Items |
(164 642)
|
11 953
|
(584 684)
|
(557 762)
|
(449 573)
|
(477 013)
|
314 325
|
197 970
|
|
Cash from Investing Activities |
(181 344)
N/A
|
(30 530)
+83%
|
(628 848)
-1 960%
|
(591 622)
+6%
|
(480 325)
+19%
|
(481 555)
0%
|
310 802
N/A
|
190 283
-39%
|
|
Financing Cash Flow | |||||||||
Net Issuance of Common Stock |
0
|
73 280
|
0
|
73 749
|
74 124
|
844
|
0
|
0
|
|
Net Issuance of Debt |
(379)
|
(416)
|
(537)
|
(466)
|
(595)
|
(786)
|
(950)
|
(1 096)
|
|
Cash Paid for Dividends |
0
|
(49 959)
|
0
|
(99 878)
|
(99 878)
|
(49 919)
|
0
|
(20 411)
|
|
Other |
(49 959)
|
50
|
0
|
49 957
|
49 967
|
(40)
|
0
|
0
|
|
Cash from Financing Activities |
(50 338)
N/A
|
22 955
N/A
|
22 834
-1%
|
23 361
+2%
|
23 617
+1%
|
(49 901)
N/A
|
(50 065)
0%
|
(21 120)
+58%
|
|
Change in Cash | |||||||||
Effect of Foreign Exchange Rates |
55 564
|
20 930
|
21 845
|
(8 275)
|
(46 682)
|
1 978
|
15 477
|
19 699
|
|
Net Change in Cash |
80 308
N/A
|
262 455
+227%
|
(349 517)
N/A
|
(531 061)
-52%
|
(486 300)
+8%
|
(533 672)
-10%
|
297 841
N/A
|
239 413
-20%
|
|
Free Cash Flow | |||||||||
Free Cash Flow |
239 724
N/A
|
206 616
-14%
|
190 488
-8%
|
11 615
-94%
|
(13 663)
N/A
|
(8 736)
+36%
|
18 104
N/A
|
42 864
+137%
|